Wiley Reports Fiscal 2025: Revenue Declines to $1.678B, Operating Income Rises to $221M, EPS Hits $1.53

Reuters
2025/06/17
Wiley Reports Fiscal 2025: Revenue Declines to $1.678B, Operating Income Rises to $221M, EPS Hits $1.53

John Wiley & Sons Inc. reported its fiscal 2025 results, highlighting a significant improvement in financial performance. The company achieved an operating income of $221 million, up from $52 million the previous year, with diluted earnings per share $(EPS)$ increasing to $1.53 from a loss of $3.65. Full-year reported revenue was $1.678 billion, down from $1.873 billion due to revenue foregone from divested businesses. However, adjusted revenue, excluding divestitures, grew by 3% at constant currency. The company's research segment showed resilience, with Q4 research revenue climbing by 4% as reported and 3% at constant currency, benefiting from growth in recurring revenue publishing models and open access. The adjusted EBITDA margin for research in Q4 rose modestly to 34.7%. Wiley exceeded its adjusted EPS guidance and significantly expanded its profit margins. The company also raised its adjusted EBITDA margin target to a range of 25.5% to 26.5%, driven by cost savings, efficiency gains, and revenue growth. Free cash flow increased by 10% to $126 million, supported by expected adjusted EBITDA growth, lower restructuring payments, and favorable working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. John Wiley & Sons Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250617821533) on June 17, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10